Featured Articles

  1. A Blueprint For Modern Obesity Research 5/6/2026

    The landscape of obesity and GLP-1 research has reached a saturation point. To successfully scale to the 5,000-patient registries now required for long-term evidence, a shift in operational architecture is essential.

  2. Strong Bookings And The Disruption Gap Nobody Is Talking About 5/6/2026

    Understand the real impact of AI on CRO valuations and clinical trial stability. Explore why market data contradicts the "disruption" narrative and what it means for the future of the industry.

  3. Early-Stage Biotech's AI Advantage Is A Window That Closes 5/6/2026

    The "greenfield" advantage allows biotechs to build AI-native trials from the start, replacing manual data entry with automated workflows and structured human oversight for better data integrity.

  4. What AI Replaces In Phase 2/3 Data Management 5/6/2026

    Explore how clinical teams are moving beyond AI hype to implement grounded strategies for automated edit checks, risk-based query management, and the regulatory frameworks needed for oversight.

  5. Real-Time Data... Are We Fixing The Right Bottleneck (Or Any For That Matter)? 5/6/2026

    Real-time data streaming to regulators is a bold step, but true clinical acceleration requires solving site-level bottlenecks and data silos to reduce the administrative burden on research.

  6. Reinventing Prostate Cancer Diagnostics With An All-In-One Platform 3/31/2026

    Discover how a lean research team saved an estimated $100k and reached 95% data compliance by unifying their clinical workflow.

  7. From Months To Hours: MMC Medical's EDC Revolution 3/31/2026

    Learn how a specialized CRO reduced study build times by 95%. Discover strategies for template reusability and flexible resource scaling to accelerate early-stage medical device validation.

  8. Executing Concurrent Decentralized RCTs And RWE At Scale 3/31/2026

    See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.

  9. 3-Week Database Builds That Withstood FDA Review 3/31/2026

    Learn how a lean clinical team deployed global, regulator-ready databases in just three weeks to secure immediate Phase 3 entry and transform reproductive health research.

  10. The Patient Experience Paradox: eCOA Strategy Overhaul 3/25/2026

    European regulatory shifts now require the systematic integration of patient data. Success depends on aligning clinical and market access strategies through rigorous evidence generation.